Philip PA - Search Results

1

Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model.

Mohammad RM, Adsay NV, Philip PA, Pettit GR, Vaitkevicius VK, Sarkar FH. Mohammad RM, et al. Among authors: philip pa. Anticancer Drugs. 2001 Oct;12(9):735-40. doi: 10.1097/00001813-200110000-00005. Anticancer Drugs. 2001. PMID: 11593055

2

Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee.

Philip PA, Rea D, Thavasu P, Carmichael J, Stuart NS, Rockett H, Talbot DC, Ganesan T, Pettit GR, Balkwill F, et al. Philip PA, et al. J Natl Cancer Inst. 1993 Nov 17;85(22):1812-8. doi: 10.1093/jnci/85.22.1812. J Natl Cancer Inst. 1993. PMID: 8230261 Clinical Trial.

3

Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.

Zalupski MM, Shields AF, Philip PA, Kraut M, LoRusso P, Heilbrun LK, Vaitkevicius V. Zalupski MM, et al. Among authors: philip pa. Invest New Drugs. 1998;16(1):93-6. doi: 10.1023/a:1006087114621. Invest New Drugs. 1998. PMID: 9740550 Clinical Trial.

4

A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancer.

Zonder JA, Shields AF, Zalupski M, Chaplen R, Heilbrun LK, Arlauskas P, Philip PA. Zonder JA, et al. Among authors: philip pa. Clin Cancer Res. 2001 Jan;7(1):38-42. Clin Cancer Res. 2001. PMID: 11205915 Clinical Trial.

5

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.

Philip PA, Zalupski MM, Vaitkevicius VK, Arlauskas P, Chaplen R, Heilbrun LK, Adsay V, Weaver D, Shields AF. Philip PA, et al. Cancer. 2001 Aug 1;92(3):569-77. doi: 10.1002/1097-0142(20010801)92:3<569::aid-cncr1356>3.0.co;2-d. Cancer. 2001. PMID: 11505401 Clinical Trial.

6

Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters.

Merati K, said Siadaty M, Andea A, Sarkar F, Ben-Josef E, Mohammad R, Philip P, Shields AF, Vaitkevicius V, Grignon DJ, Adsay NV. Merati K, et al. Am J Clin Oncol. 2001 Oct;24(5):447-52. doi: 10.1097/00000421-200110000-00007. Am J Clin Oncol. 2001. PMID: 11586094

7

Pancreatic cancer: the evolving role of systemic therapy.

Adsay NV, El-Rayes BF, Philip PA. Adsay NV, et al. Among authors: philip pa. Expert Opin Pharmacother. 2001 Dec;2(12):1939-47. doi: 10.1517/14656566.2.12.1939. Expert Opin Pharmacother. 2001. PMID: 11825326 Review.

8

A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies.

Vaishampayan UN, Ben-Josef E, Philip PA, Vaitkevicius VK, Du W, Levin KJ, Shields AF. Vaishampayan UN, et al. Among authors: philip pa. Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):675-9. doi: 10.1016/s0360-3016(02)02772-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12062611

9

Gemcitabine and platinum combinations in pancreatic cancer.

Philip PA. Philip PA. Cancer. 2002 Aug 15;95(4 Suppl):908-11. doi: 10.1002/cncr.10757. Cancer. 2002. PMID: 12209670 Free article. Review.

10

Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians.

Pernick NL, Sarkar FH, Philip PA, Arlauskas P, Shields AF, Vaitkevicius VK, Dugan MC, Adsay NV. Pernick NL, et al. Among authors: philip pa. Pancreas. 2003 Jan;26(1):28-32. doi: 10.1097/00006676-200301000-00006. Pancreas. 2003. PMID: 12499914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters